Market Outlook

By 2035, the U.S. 5G Connected Medical Devices Market is expected to reach approximately USD 43.87 billion, expanding at an aggressive CAGR of 26.00% during the forecast period 2026–2035. The market is estimated at USD 4.35 billion in 2025, following expansion from approximately USD 1.42 billion in 2021, USD 1.82 billion in 2022, USD 2.38 billion in 2023, and USD 3.19 billion in 2024. Values in this report are expressed in USD billions.

The U.S. 5G connected medical devices industry sits at the intersection of regulated medical technology, private wireless infrastructure, edge computing, remote patient management, clinical mobility, and hospital digital transformation. Unlike the broader Internet of Medical Things market, this report focuses specifically on medical devices for which 5G connectivity, a 5G-capable gateway, private 5G integration, or 5G-supported clinical data transmission forms a meaningful part of device functionality, deployment economics, or care-delivery workflow. General-purpose smartphones, conventional telecom services, unrelated enterprise networking equipment, and consumer devices that do not perform a medical function are excluded from the core market estimate.

The addressable opportunity is expanding rapidly because the U.S. has moved beyond the early 5G coverage-building cycle. More than 259 million active 5G devices were already connected nationally in 2024, while nationwide networks collectively reach approximately 332 million Americans. This gives medical device manufacturers a substantially larger installed connectivity base on which to design cellular-first monitoring, home healthcare, imaging, emergency medicine, smart-hospital, and mobile diagnostic platforms.

Hospitals are simultaneously becoming more device-dense. The U.S. healthcare system includes approximately 6,100 hospitals, more than 907,000 staffed hospital beds, and more than 35 million annual hospital admissions. A large tertiary hospital may operate thousands of connected endpoints across bedside monitoring, infusion management, imaging, asset management, staff communications, patient surveillance, telemetry, laboratory operations, and mobile clinical workflows. As these environments become more data-intensive, connectivity performance is shifting from an IT consideration toward a clinical-operational requirement.

The historical market accelerated from USD 1.42 billion in 2021 to USD 3.19 billion in 2024, supported by nationwide 5G deployment, expansion of cellular-enabled remote monitoring, post-pandemic normalization of virtual care, growing use of connected diagnostics, and early private 5G hospital deployments. The market reached an estimated USD 4.35 billion in 2025 as health systems increasingly evaluated private 5G, neutral-host infrastructure, edge-connected medical devices, smart beds, continuous monitoring platforms, connected imaging, and cellular-first home monitoring.

Between 2026 and 2035, the commercial transition will move from simply connecting devices to guaranteeing clinical-grade connectivity. The winning technologies will be those that combine low-latency transmission, network segmentation, device identity management, cybersecurity, interoperability, continuous software support, EHR integration, and measurable improvements in clinical workflow economics. Device manufacturers will increasingly be evaluated not only on diagnostic or therapeutic performance but also on how reliably their devices operate across hospital, ambulatory, emergency, and home environments.

 

Introduction

According to the U.S. 5G Connected Medical Devices Market Report, 5G is emerging as an enabling infrastructure layer for the next generation of digitally connected healthcare rather than functioning as a standalone clinical technology. Its commercial importance derives from its ability to support high device density, mobility, dependable wireless coverage, quality-of-service differentiation, stronger identity-based network control, high bandwidth, and lower latency than many legacy connectivity architectures.

The healthcare case for 5G is different from the consumer smartphone case. Hospitals do not adopt new networks simply because higher speeds are available. Health systems require predictable performance for mobile patient monitors, connected infusion systems, imaging applications, tele-ICU workflows, smart beds, virtual nursing, medical-grade wearables, robotic systems, emergency communications, and mobile diagnostics. Network outages, handoff failures, congestion, interference, or cybersecurity weaknesses may affect workflow continuity and, in higher-acuity situations, patient safety.

Remote care adds another layer of opportunity. Medicare remote patient monitoring now recognizes connected medical devices that digitally transmit physiological measurements such as blood pressure, weight, oxygen saturation, and other patient data. Medicare payments for remote patient monitoring exceeded USD 500 million in 2024, demonstrating that connected monitoring has evolved into a meaningful reimbursed care model rather than remaining a technology pilot. Approximately 71.4% of physicians reported using telehealth in their practices in 2024, while remote patient monitoring usage was materially higher among hospital-owned practices than among private practices.

The industry is therefore developing through two parallel architectures. The first is public 5G connectivity, which supports devices operating outside hospitals, including home monitoring, emergency response, mobile diagnostics, ambulatory monitoring, and connected chronic-disease management. The second is private or hybrid 5G, where hospitals create dedicated wireless environments for medical equipment, clinicians, operational devices, and bandwidth-intensive applications.

This distinction is important for buyers. A hospital may use neutral-host infrastructure for visitors and conventional mobile users while deploying a private 5G environment for mission-critical devices, asset tracking, smart beds, clinical mobility, imaging transfer, and future autonomous or AI-enabled applications. This architecture allows healthcare systems to separate clinical traffic from public connectivity while preserving roaming and mobility.

Cybersecurity is equally central to market development. Internet-connected medical devices that meet the FDA definition of a cyber device face increasingly explicit cybersecurity requirements. Manufacturers must account for vulnerability management, secure product development, software components, postmarket security, and lifecycle resilience. Consequently, 5G adoption is not simply increasing connectivity spending; it is changing product-development requirements, supplier qualification, hospital technology assessment, and lifecycle service economics.

The U.S. market is expected to move progressively toward devices designed around connectivity-by-design rather than connectivity added after product development. This will favor manufacturers that integrate embedded cellular modules, eSIM capabilities, secure device identity, cloud management, edge analytics, over-the-air software maintenance, and interoperability into the original device architecture.

 

Key Market Drivers: What’s Fueling the U.S. 5G Connected Medical Devices Market Boom?

The first major growth driver is the scale of the U.S. 5G installed base. Approximately 259 million active 5G devices were present in the U.S. during 2024, representing roughly 45% of wireless connections. National 5G coverage now reaches approximately 332 million Americans, while median wireless download speeds have moved above 150 Mbps. This network maturity substantially reduces the commercialization risk for medical device companies designing products around cellular connectivity.

The second driver is the transformation of hospitals into high-density connected environments. The U.S. has more than 907,000 staffed hospital beds, and hospital systems increasingly operate electronic medical records, digital imaging, mobile workstations, bedside monitoring, telehealth, smart beds, clinical communication systems, tracking technologies, and connected medical equipment simultaneously. Shared networks must therefore support increasingly diverse traffic profiles. Private 5G provides health systems with another network architecture for isolating clinical workloads, managing device identities, allocating capacity, and supporting future applications.

Remote patient monitoring is a third powerful driver. Medicare has covered RPM since 2018, and annual payments exceeded USD 500 million in 2024. Connected blood pressure devices, weight scales, pulse oximeters, cardiac monitors, glucose monitoring systems, respiratory devices, and other physiological monitoring technologies can automatically transmit data to providers. 5G becomes particularly valuable when devices operate outside dependable home Wi-Fi environments, serve elderly or technically inexperienced patients, or require continuous rather than episodic communication.

A fourth driver is clinical mobility. Medical care increasingly occurs across rooms, floors, buildings, outpatient facilities, ambulances, homes, and community settings. Devices designed around fixed Ethernet or inconsistent Wi-Fi access can create workflow friction when they move with patients or clinicians. Cellular-connected equipment can reduce dependence on manual reconnection, local password management, and heterogeneous network environments. This becomes particularly relevant for telemetry, mobile imaging, emergency response, continuous monitoring, smart beds, transport monitors, and mobile diagnostic carts.

A fifth driver is the increasing data intensity of medical technology. Diagnostic imaging, AI-supported interpretation, high-resolution video, digital pathology, wearable biosignals, robotic systems, virtual nursing, and multi-parameter monitoring generate considerably larger and more continuous data volumes than traditional standalone devices. Physicians are also using AI more extensively: approximately two-thirds of U.S. physicians reported using some form of healthcare AI during 2024. As AI moves closer to medical-device workflows, hospitals will require networks capable of moving data efficiently between devices, edge infrastructure, clinical applications, and cloud platforms.

A sixth driver is healthcare workforce economics. Hospitals continue to face pressure around nursing availability, specialist access, throughput, and labor productivity. Connectivity technologies that support centralized monitoring, virtual nursing, remote specialist consultation, automated asset location, digital workflow orchestration, and fewer manual device checks can generate value even if the direct network cost is higher. Procurement committees will increasingly assess 5G-connected devices through labor savings and workflow capacity rather than through connectivity cost alone.

A seventh driver is rural and emergency care. Public 5G networks can connect portable diagnostic equipment, ambulance telemetry, mobile ultrasound, remote monitoring devices, and specialist consultation workflows without requiring the care setting to maintain enterprise-grade local networking. First-responder connectivity and priority wireless services are particularly relevant when emergency departments, ambulances, public safety agencies, and hospital command centers need continuous communication during periods of high network demand.

Finally, hospital capital cycles will accelerate adoption. New towers, greenfield hospitals, smart-hospital projects, major renovations, and enterprise wireless refresh programs create natural windows for private 5G investment. Deploying medical-device connectivity infrastructure during initial construction can be economically easier than retrofitting complex facilities after commissioning.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. 5G connected medical devices market is shifting from raw connectivity performance toward clinical-grade wireless architecture. Healthcare buyers increasingly want devices that can remain connected as they move across care environments, authenticate automatically, prioritize critical traffic, communicate securely, and maintain software integrity throughout long product lifecycles.

Private 5G represents one of the most strategically important innovations. Instead of placing every connected endpoint on a shared enterprise Wi-Fi environment, hospitals can provision designated medical and operational devices onto dedicated wireless infrastructure. This model supports greater control over authentication, device policies, traffic separation, mobility, bandwidth allocation, and network performance. Major U.S. health systems are already evaluating or deploying combined neutral-host and private 5G architectures.

Edge computing is another major development. Medical data does not always need to travel to a distant cloud environment before it becomes clinically useful. 5G-connected devices combined with on-premises or metro-edge computing can support lower-latency analytics, real-time image processing, alarm prioritization, video analysis, virtual-care applications, and AI inference. This architecture is especially relevant when high data volumes or time-sensitive decisions make cloud-only processing inefficient.

The integration of eSIM and embedded cellular connectivity is expected to reshape device lifecycle management. Rather than requiring physical SIM replacement or depending entirely on local hospital Wi-Fi credentials, manufacturers can design devices that are provisioned centrally and transferred more easily between approved networks. For home healthcare manufacturers, this could significantly reduce patient setup complexity.

5G Reduced Capability, often referred to as 5G RedCap, is another important future development. Many medical devices do not require smartphone-class bandwidth but need better power efficiency and cost economics than full-performance 5G modules. RedCap creates a potential connectivity tier for wearables, monitoring devices, portable medical equipment, and industrial-style healthcare IoT applications. Commercial medical adoption will depend on module availability, regulatory validation, carrier support, product development cycles, and battery requirements.

Cybersecurity-by-design is becoming inseparable from connectivity innovation. The latest FDA expectations place greater emphasis on secure development, threat assessment, vulnerability management, software transparency, and postmarket security. Device manufacturers will therefore compete on security architecture alongside clinical performance. Embedded identity, encrypted communication, secure boot, network segmentation compatibility, software bills of materials, patch management, and controlled over-the-air updates will increasingly influence hospital vendor qualification.

Interoperability is also becoming a competitive differentiator. The value of a connected device increases when its information can flow into EHRs, alarm-management systems, central monitoring platforms, imaging archives, clinical dashboards, and analytics environments without creating additional manual workflows. Manufacturers that combine 5G connectivity with standards-based interoperability and enterprise management capabilities can move from device supplier to strategic health-system platform partner.

 

Segmentation Insights

The U.S. 5G Connected Medical Devices Market is segmented by device type, connectivity architecture, application, end user, and region. These five segmentation dimensions capture both the clinical and infrastructure layers that determine commercial adoption.

 

By Device Type

Patient Monitoring and Diagnostic Devices

Patient monitoring and diagnostic systems represent the largest near-term device opportunity and are estimated to account for roughly one-third of the market in 2025. The category includes multi-parameter monitors, ECG systems, ambulatory cardiac monitors, blood pressure devices, pulse oximeters, continuous glucose monitoring ecosystems, respiratory monitoring, connected spirometry, portable diagnostic tools, and other systems that transmit physiological data.

The commercial case for 5G is strongest where monitoring must continue across hospital departments or beyond hospital walls. Continuous connectivity can reduce gaps caused by local network changes and supports centralized surveillance models. As hospitals increase virtual nursing and remote observation, the ability to move high-frequency patient data reliably becomes increasingly valuable.

Therapeutic and Life-Support Devices

This subsegment includes connected infusion systems, respiratory therapy devices, insulin-delivery systems, dialysis equipment, implantable monitoring or therapeutic systems, ventilatory support platforms, and other digitally managed therapeutic equipment.

Connectivity in therapeutic devices carries a higher clinical and cybersecurity burden because communication failures or unauthorized access may influence treatment delivery. Manufacturers therefore require strong authentication, network isolation, fail-safe device behavior, and secure software-update architecture. Growth will be driven less by adding 5G simply for marketing differentiation and more by clinical use cases in which mobility, remote management, or guaranteed wireless performance generates measurable workflow value.

Medical Imaging and Visualization Systems

Imaging systems create particularly demanding bandwidth requirements. Portable ultrasound, mobile imaging equipment, endoscopy, connected visualization platforms, digital pathology devices, and image-guided procedural systems increasingly interact with cloud or edge-based analysis.

5G can enable faster transfer of large imaging files, mobile image acquisition, remote consultation, AI inference, and distributed specialist workflows. Adoption will initially concentrate in large academic systems, trauma networks, mobile diagnostic environments, and hospitals with significant imaging and AI infrastructure.

Surgical, Robotic, and Interventional Systems

Robotic surgery, image-guided intervention, digital operating rooms, navigation platforms, procedural video systems, and remote technical support are strategically important high-value applications. Full remote surgery remains a specialized and technically demanding use case; however, nearer-term opportunities include remote proctoring, device support, intraoperative video collaboration, robotic telemetry, and connected procedural equipment.

The segment will remain smaller in unit volume than monitoring but can command substantial value because systems are capital-intensive and are purchased within broader digital operating-room strategies.

Wearable and Home Healthcare Devices

Wearables and home devices represent one of the fastest-growing categories through 2035. Cardiac patches, continuous glucose systems, connected respiratory devices, blood pressure monitors, pulse oximeters, weight scales, rehabilitation sensors, sleep devices, and chronic-disease monitoring equipment are increasingly used outside conventional facilities.

The strategic value of cellular connectivity is that the patient does not need to configure a home Wi-Fi network. This can improve deployment reliability among older adults, rural populations, post-discharge patients, and individuals with limited technical capability. As RPM reimbursement and hospital-at-home programs expand, integrated cellular connectivity will become an increasingly important product-design consideration.

 

By Connectivity Architecture

Public 5G Networks

Public 5G currently represents the largest addressable connectivity architecture because nationwide carrier infrastructure already exists and supports devices operating across homes, ambulances, clinics, outpatient settings, and community environments.

Public 5G is particularly suitable for home monitoring, emergency services, mobile diagnostics, wearable monitoring, post-discharge care, and devices requiring broad geographic mobility. Carrier certification, coverage quality, data economics, and roaming strategy remain critical commercial variables.

Private 5G Networks

Private 5G is expected to be one of the fastest-growing architectures through 2035. Hospitals can create controlled wireless environments for selected clinical and operational endpoints without routing every application through the same public-facing infrastructure.

The model is gaining relevance for connected medical equipment, smart beds, mobile workstations, location services, imaging applications, automation, clinical communications, and future autonomous systems. Private 5G is especially attractive for new hospitals and large campuses where network architecture can be designed around long-term digital requirements.

Hybrid 5G and Wi-Fi Architectures

Hybrid environments will remain common because health systems have extensive existing Wi-Fi investments. Medical devices may use Wi-Fi for some workflows while cellular connectivity provides mobility, failover, external coverage, or mission-specific network separation.

The most commercially successful products will avoid forcing buyers into a single connectivity model. Devices capable of operating securely across Wi-Fi, private 5G, public cellular, and wired networks can reduce procurement risk and fit more naturally into heterogeneous hospital environments.

5G Edge-Enabled Connectivity

Edge-enabled architectures combine 5G with computing resources located close to the device or hospital. This reduces the need to move every data stream into centralized cloud infrastructure before analysis occurs.

Use cases include real-time video analytics, imaging AI, patient deterioration algorithms, connected procedural systems, AR-assisted workflows, centralized monitoring, and computationally intensive medical applications. Edge adoption will be concentrated initially in larger systems capable of supporting sophisticated network and application orchestration.

5G RedCap and Low-Power Cellular Architectures

Reduced-capability 5G technologies are expected to expand later in the forecast period as device modules become smaller, more power-efficient, and economically suitable for lower-bandwidth medical applications.

The strongest opportunities include wearables, sensors, monitoring devices, connected rehabilitation equipment, and portable diagnostics. RedCap has the potential to bridge the gap between high-performance 5G and lower-power cellular IoT technologies while giving manufacturers a longer migration path toward future 5G-based networks.

 

By Application

Remote Patient Monitoring

Remote patient monitoring represents the clearest scalable 5G medical-device application. Medicare payments exceeded USD 500 million in 2024, and connected physiological monitoring now covers both chronic and acute conditions.

Cellular-first devices reduce dependence on patient-owned broadband and can improve data continuity. Cardiology, hypertension, diabetes, respiratory care, weight management, post-surgical surveillance, and heart-failure management represent important clinical opportunities.

Real-Time Hospital Patient Monitoring

Continuous telemetry, bedside monitoring, transport monitoring, deterioration surveillance, and central monitoring are major hospital use cases. The business case centers on mobility, fewer disconnected endpoints, centralized observation, and improved alarm or workflow management.

Large health systems increasingly evaluate connectivity according to whether it supports nursing productivity and patient throughput. 5G-enabled monitoring solutions that reduce manual reconnection or device-management tasks can therefore create value beyond conventional networking performance.

Telemedicine and Virtual Care

Approximately 71.4% of U.S. physicians reported using telehealth in their practices in 2024, demonstrating the durability of digitally mediated care after the pandemic. 5G expands the range of virtual care beyond conventional video visits by supporting connected examination devices, diagnostic peripherals, remote imaging, high-definition video, and continuous physiological data.

Virtual nursing, tele-ICU, remote specialist consultation, rural diagnostics, and emergency telemedicine are among the most attractive institutional applications.

Connected Surgery and Procedural Support

5G can support high-resolution procedural video, remote proctoring, robotics, navigation systems, equipment telemetry, augmented-reality assistance, and specialist collaboration.

The near-term commercial opportunity is more likely to come from connected procedural ecosystems and remote support than fully remote autonomous surgery. Hospitals will require deterministic performance, rigorous cybersecurity, redundancy, and fail-safe architecture before allowing network dependence within critical procedural workflows.

Asset Intelligence and Clinical Operations

Although some asset-tracking technologies are not themselves medical devices, device connectivity and location intelligence are increasingly integrated into medical equipment fleets. Hospitals need to identify the location, availability, maintenance status, and utilization of pumps, monitors, beds, portable imaging equipment, respiratory devices, and other mobile assets.

5G-connected device management can reduce equipment search time, improve utilization, support preventive maintenance, and decrease unnecessary capital purchases. These operational savings can strengthen the investment case for connected-device programs even when direct clinical ROI is difficult to quantify.

 

By End User

Hospitals and Integrated Health Systems

Hospitals and health systems represent the dominant end-user category and are estimated to generate more than half of U.S. market revenue in 2025. Their demand spans bedside monitoring, imaging, connected therapy, smart beds, surgical platforms, virtual nursing, asset intelligence, emergency communications, and private wireless infrastructure.

Large integrated delivery networks increasingly evaluate connected devices through enterprise architecture committees in addition to traditional value-analysis committees. Cybersecurity, interoperability, network certification, software lifecycle commitments, and fleet-management capabilities can therefore affect purchasing alongside clinical evidence.

Ambulatory and Specialty Care Centers

Outpatient centers are increasingly technology-intensive but generally operate with tighter capital and staffing economics than tertiary hospitals. 5G-connected diagnostic, monitoring, imaging, and procedural devices can support compact infrastructure and centralized specialist oversight.

Cardiology, oncology, dialysis, orthopedics, gastroenterology, and multispecialty outpatient centers represent important opportunities as care continues shifting away from inpatient environments.

Diagnostic and Imaging Providers

Imaging centers and diagnostic networks benefit from rapid transfer of large files, remote specialist interpretation, AI-enabled image processing, and mobile diagnostic equipment.

The value proposition is particularly strong when providers operate multiple sites but want centralized radiology, cardiology, pathology, or specialist resources. Connectivity that enables distributed acquisition with centralized analysis can improve equipment and workforce utilization.

Home Healthcare and Remote Monitoring Providers

Home care is expected to be the fastest-growing end-user setting. Cellular-enabled devices reduce dependence on patient broadband, allow automated data transmission, and enable providers to manage larger patient populations remotely.

The most successful platforms will combine simple patient onboarding with clinician dashboards, exception-based workflow, EHR integration, reimbursement support, adherence tracking, and reliable device connectivity.

Emergency, EMS, and Rural Care Providers

Emergency medical services, rural hospitals, critical-access facilities, mobile clinics, and community health programs can benefit disproportionately from 5G connectivity because local specialist capacity and wired infrastructure may be limited.

Connected ultrasound, patient telemetry, portable diagnostics, video consultation, and pre-arrival transmission of clinical data can extend specialist expertise into ambulances and remote settings. Priority cellular services and network resilience are particularly important within this segment.

 

Regional Insights: Where the Market Is Growing Fastest

The U.S. 5G Connected Medical Devices Market is geographically segmented into the South, West, Northeast, and Midwest. Regional opportunity depends on more than population. Health-system concentration, 5G infrastructure, private-network investment, academic medical centers, digital-health innovation, rural access requirements, home healthcare adoption, payer composition, hospital construction, and technology procurement maturity all influence market development.

In 2025, the South represents an estimated USD 1.42 billion, the West approximately USD 1.22 billion, the Northeast around USD 0.96 billion, and the Midwest approximately USD 0.75 billion. Combined, these values align with the national 2025 market estimate of USD 4.35 billion. The South is currently the largest regional market, while the West is expected to record the fastest growth through 2035.

South

The South represents the largest U.S. regional opportunity, accounting for an estimated USD 1.42 billion in 2025 and potentially reaching approximately USD 13.62 billion by 2035. Its growth is supported by population expansion, large metropolitan hospital systems, high chronic-disease burden, significant rural populations, rising home healthcare demand, and extensive investment in new medical infrastructure.

Texas and Florida are the region’s most important state markets. Texas combines major medical centers in Houston, Dallas-Fort Worth, Austin, and San Antonio with rapid population growth and a strong telecom infrastructure ecosystem. Health systems in the state are increasingly evaluating advanced wireless capabilities for connected clinical operations. Children’s Health in North Texas is one example of a major provider using enhanced 5G connectivity to support hospital communications and digital care requirements.

Florida is strategically important because of its older population and high demand for chronic-disease management, cardiovascular monitoring, respiratory care, diabetes management, and post-acute services. Large multi-hospital systems create opportunities for enterprise connected-device deployments rather than isolated pilot projects.

Florida has also emerged as a visible private-network market. Major health systems including AdventHealth and Tampa General Hospital have pursued advanced on-premises wireless infrastructure. These projects are strategically important because they move private 5G from laboratory testing toward operational hospital architecture involving smart beds, real-time location services, asset tracking, wayfinding, and future connected medical-device capacity.

Georgia, North Carolina, Tennessee, and Virginia represent strong secondary growth markets. North Carolina benefits from major academic health systems and a substantial technology and life-sciences ecosystem. Georgia combines Atlanta’s large health system concentration with rural-access challenges outside major metropolitan areas. Tennessee has large hospital operators and healthcare-service companies, making it important for enterprise-scale deployment models.

Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, and West Virginia present a different opportunity profile. These markets generally contain fewer large technology-leading hospitals, but higher chronic-disease burdens and rural access challenges can increase the value of home monitoring, connected respiratory devices, mobile diagnostics, remote specialist services, and EMS connectivity.

The South is expected to remain the largest market through most of the forecast period. Its advantage comes from the combination of high patient volume and the ability to deploy 5G in multiple care models: tertiary hospitals, suburban growth markets, rural networks, home healthcare, and emergency services.

West

The West generated an estimated USD 1.22 billion in 2025 and is forecast to become approximately a USD 13.78 billion market by 2035, implying regional growth faster than the national average. The West is expected to emerge as the most innovation-intensive market because of its concentration of digital-health companies, academic institutions, wireless technology developers, AI firms, medtech manufacturers, and sophisticated integrated delivery networks.

California dominates the region. The state combines one of the nation’s largest healthcare markets with Silicon Valley, major wireless and semiconductor ecosystems, leading academic medical centers, integrated providers, and venture-backed medical technology companies. California is therefore especially important for early commercialization of cellular-connected monitoring, AI-enabled devices, hospital edge computing, connected imaging, and remote diagnostic technologies.

The VA Palo Alto Health Care System has also served as an important test bed for private and hybrid 5G healthcare infrastructure. Such projects are commercially significant because they allow medical-device manufacturers, network suppliers, and health systems to validate connectivity requirements in real clinical environments rather than controlled demonstrations.

California’s value extends beyond hospital deployment. The state has a large addressable population for diabetes technology, cardiac monitoring, remote respiratory care, home health, post-acute management, and digitally supported chronic care. Manufacturers able to secure adoption within major California systems can generate clinical evidence and implementation models that influence purchasing nationally.

Washington and Oregon are attractive because their provider markets include sophisticated integrated health systems and strong adoption of cloud, digital health, and connected-care workflows. Washington also benefits from a deep technology workforce, making it favorable for AI-device integration and enterprise digital architecture.

Arizona and Nevada are among the strongest demographic growth opportunities. Aging populations, rapid metro-area expansion, and new healthcare construction create natural demand for smart-hospital infrastructure and connected chronic-care technologies. Arizona is particularly attractive for cardiac monitoring, diabetes management, respiratory care, and home-based services.

Colorado and Utah offer strong digital-health and health-system ecosystems with comparatively high technology adoption. Their integrated delivery networks can serve as early adopters for private wireless, remote monitoring, and distributed-care applications.

Idaho, Montana, Wyoming, Alaska, New Mexico, and Hawaii are smaller device markets but strategically important for telemedicine and remote care. Geographic distance between patients and specialist centers increases the value of portable diagnostics, cellular-connected medical equipment, remote physiological monitoring, and mobile clinical services.

The West is expected to gain national share through 2035 as 5G-connected medical devices increasingly converge with AI, edge computing, wearables, cloud-based diagnostics, and distributed care.

Northeast

The Northeast represented an estimated USD 0.96 billion in 2025 and is projected to reach approximately USD 9.12 billion by 2035. Although population growth is slower than in the South and West, the region has a disproportionate concentration of academic medical centers, sophisticated hospital networks, medical research organizations, specialist physicians, and innovation-driven purchasing.

New York is the largest state market in the Northeast. Its large hospital systems, dense patient population, academic centers, and complex care environment make the state attractive for connected monitoring, imaging, hospital mobility, virtual nursing, and network modernization.

Massachusetts has outsized strategic importance because of Boston’s academic medical, biotechnology, medtech, and digital-health ecosystem. Early-stage 5G-enabled medical-device companies can access clinical collaborators, research infrastructure, engineering talent, and major healthcare buyers in a relatively concentrated geography. Massachusetts is therefore particularly important for product validation and clinical evidence generation.

Pennsylvania and New Jersey offer large health-system markets with significant acute-care, pharmaceutical, technology, and specialty-care infrastructure. Pennsylvania’s major metropolitan markets can support private 5G and enterprise device deployments, while New Jersey benefits from proximity to New York and a strong life-sciences commercial base.

Connecticut, Rhode Island, New Hampshire, Vermont, Maine, and Delaware are smaller markets individually but provide opportunities in integrated health networks, chronic-care monitoring, rural telemedicine, and specialty medicine.

Procurement within the Northeast tends to be evidence-intensive. Manufacturers may face longer evaluation cycles but can gain significant credibility from deployments within leading academic institutions. Cybersecurity documentation, interoperability, clinical validation, and integration with existing enterprise technology platforms are particularly important.

Midwest

The Midwest accounted for approximately USD 0.75 billion in 2025 and could reach about USD 7.35 billion by 2035. The region offers a large installed hospital base, influential medical-device manufacturers, major academic health systems, community hospitals, rural provider networks, and substantial chronic-disease demand.

Illinois, Ohio, Michigan, and Minnesota represent the largest state opportunities. Chicago provides Illinois with a dense hospital and academic ecosystem suited to advanced connected-care technologies. Ohio is particularly important because of its major health systems and early private 5G healthcare initiatives. Cleveland Clinic’s deployment of private 5G infrastructure at its Mentor facility illustrates how advanced connectivity can be built directly into new hospital environments.

Minnesota has unusual strategic significance because of its medtech manufacturing heritage. The state is home to major device companies, engineering capabilities, cardiac technology expertise, and sophisticated healthcare systems. As embedded cellular connectivity becomes more common in regulated devices, Minnesota can influence product-development activity in addition to end-user adoption.

Michigan, Indiana, Wisconsin, and Missouri offer large community health-system markets where connected-device purchasing will depend heavily on operational ROI. Solutions that reduce nursing workload, improve equipment utilization, support regional specialist coverage, or lower readmission risk are likely to outperform technologies positioned primarily around connectivity speed.

Iowa, Kansas, Nebraska, North Dakota, and South Dakota are smaller markets but provide strong use cases for remote patient monitoring and rural care. Long travel distances and specialist shortages increase the potential value of cellular-connected diagnostic equipment, home monitoring, tele-ICU technologies, and emergency data transmission.

The Midwest is expected to remain a durable market rather than the fastest-growing one. Manufacturers that demonstrate reliability, enterprise interoperability, service support, cybersecurity, and measurable labor or clinical benefits will be well positioned.

 

Key Market Players

The U.S. 5G Connected Medical Devices Competitive Landscape is fragmented across medical-device manufacturers, connected-care specialists, wireless carriers, network infrastructure companies, semiconductor providers, and private-network technology firms. Unlike traditional device categories, competitive advantage depends on cooperation across this ecosystem.

Medical-device companies control clinical workflows and regulatory clearances, while telecom and networking companies provide the connectivity layer. Semiconductor and module suppliers determine device power consumption, radio capability, certification economics, and product form factor. Consequently, partnerships will be as important as direct competition.

Some of the key players relevant to the U.S. 5G Connected Medical Devices Market include:

Abbott Laboratories
Medtronic
GE HealthCare
Philips Healthcare
Siemens Healthineers
Baxter International
Becton, Dickinson and Company
Boston Scientific Corporation
Johnson & Johnson MedTech
Dexcom
Insulet Corporation
ResMed
iRhythm Technologies
Masimo
Stryker
Zimmer Biomet
Verizon Business
AT&T
T-Mobile for Business
Ericsson
Nokia
Qualcomm Technologies
Cisco Systems
Celona

Medical-device leaders such as Abbott, Medtronic, Dexcom, iRhythm, ResMed, Philips, GE HealthCare, Siemens Healthineers, Baxter, and BD are well positioned because they already control large connected-device installed bases or hospital workflows. Their long-term opportunity is to determine where native cellular connectivity creates enough clinical or operational value to justify redesigning existing product platforms.

Verizon, AT&T, and T-Mobile are strategically important because public 5G coverage, carrier certification, private wireless, edge services, and healthcare-specific enterprise solutions determine how devices connect beyond controlled local environments.

Ericsson, Nokia, Cisco, Qualcomm, and Celona contribute network, radio, chipset, private wireless, edge, device-management, and infrastructure capabilities. Their ability to work directly with health systems and medical-device manufacturers will influence how rapidly standardized healthcare 5G architectures emerge.

Competition through 2035 will increasingly center on platform interoperability, embedded connectivity, cybersecurity architecture, device fleet management, clinical workflow integration, enterprise contracting, carrier flexibility, and total lifecycle economics. Manufacturers that treat 5G as a simple communications module risk commoditization. Companies that convert connectivity into fewer workflow interruptions, easier deployment, better monitoring continuity, lower IT burden, and more scalable care delivery will capture the strongest value.

 

Recent Developments

Recent U.S. market developments show that 5G in healthcare is moving from isolated proof-of-concept programs toward infrastructure decisions tied to actual hospital operations.

In February 2026, the FDA issued updated final cybersecurity guidance for medical devices with cybersecurity risk. The guidance reinforces regulatory expectations around security throughout device design and premarket documentation and directly affects manufacturers developing internet-connected and 5G-capable products. Cybersecurity is therefore becoming an integral part of product commercialization rather than a post-launch IT responsibility.

During 2025, major U.S. healthcare providers expanded their use of advanced on-premises wireless networks. AdventHealth and Tampa General Hospital were among the systems pursuing neutral-host and private 5G architectures designed to support increasingly device-dense hospital environments. Planned and emerging applications include smart beds, real-time location services, asset tracking, connected equipment, wayfinding, and future clinical technologies.

Tampa General’s network modernization is notable because the architecture incorporates the option to activate private 5G capabilities as future medical, research, and operational requirements develop. This approach may become increasingly attractive to hospital executives because it allows infrastructure modernization without requiring every 5G clinical use case to be financially justified on day one.

AT&T has also expanded healthcare-focused 5G connectivity initiatives, including work supporting Children’s Health in North Texas. Such deployments illustrate that hospital 5G adoption is being driven by day-to-day operational requirements—communications, mobility, data accessibility, and digital workflow—as much as futuristic applications such as robotics.

Private 5G initiatives at Cleveland Clinic and the VA Palo Alto Health Care System continue to provide reference architectures for hospital connectivity. These projects are important to medical-device companies because they demonstrate that regulated devices will increasingly operate in heterogeneous environments involving Wi-Fi, public 5G, private networks, local edge infrastructure, and enterprise security controls.

Meanwhile, remote patient monitoring continues to become economically meaningful. Medicare RPM payments exceeded USD 500 million in 2024, strengthening the business case for connected medical devices that can transmit physiological data automatically. As RPM scales, cellular-first designs may gain adoption where manufacturers and healthcare providers want to minimize patient setup requirements and dependence on home broadband.

The next development cycle will increasingly focus on standardized 5G support inside medical devices themselves. Embedded cellular modules, eSIM, RedCap, private-network compatibility, network slicing capabilities, secure provisioning, and seamless public/private network transitions are expected to become more important product-selection criteria over the forecast period.

 

Conclusion

The U.S. 5G Connected Medical Devices Market Size & Share is projected to increase from USD 4.35 billion in 2025 to approximately USD 43.87 billion by 2035, expanding at a CAGR of 26.00% from 2026 to 2035. Historical expansion from approximately USD 1.42 billion in 2021 reflects the transition from early 5G healthcare pilots toward commercially scalable connected monitoring, digital hospital, remote care, imaging, and clinical mobility applications.

The market’s long-term value proposition is not simply faster wireless transmission. The strategic opportunity is the creation of medical devices that can remain securely connected throughout the patient journey—from hospital admission and procedural care to discharge, home monitoring, ambulatory follow-up, and emergency intervention.

Remote patient monitoring will provide one of the largest scalable demand pools. Private 5G will become increasingly important for hospitals seeking greater control over device-dense clinical environments. Edge-connected imaging, AI-enabled monitoring, virtual nursing, smart beds, connected therapeutic devices, and mobile diagnostics will broaden the addressable market. RedCap and embedded eSIM technologies may eventually make cellular connectivity economical for a much wider range of lower-power medical equipment.

Cybersecurity will function simultaneously as a market restraint and competitive differentiator. FDA requirements for internet-connected cyber devices mean manufacturers must incorporate vulnerability management, software transparency, secure development, and lifecycle support into product economics. Hospitals will increasingly favor vendors capable of supporting security and interoperability over ten-year device lifecycles rather than suppliers offering connectivity without a sustainable software strategy.

Regional growth will remain concentrated in the South and West, with Texas, Florida, California, Arizona, North Carolina, Georgia, Washington, and Colorado benefiting from population growth, hospital investment, digital adoption, and expanding chronic-care requirements. The Northeast will remain critical for early clinical adoption and evidence generation, particularly in New York and Massachusetts. The Midwest, led by Ohio, Illinois, Minnesota, and Michigan, will provide a strong market for operationally proven connected-device solutions and rural-care applications.

For medical-device companies, the central strategic question is no longer whether hospitals and patients will become more connected. The question is which devices require sufficiently dependable mobility, data throughput, security, or continuous connectivity to justify 5G integration.

For hospitals and health systems, the decision is similarly evolving from “Should we deploy 5G?” toward “Which clinical and operational workloads warrant private or cellular-grade connectivity, and how should those networks coexist with Wi-Fi and existing infrastructure?”

For investors, suppliers, and technology partners, the most attractive opportunities will sit at the points where connectivity produces measurable clinical economics: fewer disconnected devices, lower setup burden, better monitoring adherence, more efficient nursing workflows, faster data availability, improved asset utilization, expanded specialist access, and scalable care outside the hospital.

The companies that capture disproportionate value through 2035 will therefore not be those that merely attach a 5G modem to an existing product. Market leadership will favor manufacturers that redesign medical devices around secure connectivity, clinical mobility, interoperability, lifecycle cybersecurity, edge intelligence, and demonstrable healthcare-system ROI.

 

TABLE OF CONTENT

1. U.S. 5G Connected Medical Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Bottom-Up and Top-Down Market Estimation
1.3.6. Analytical Frameworks & Forecasting Models
1.3.7. Data Triangulation, Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Inclusion and Exclusion Criteria
1.6. Market Ecosystem Overview
1.7. Stakeholder Analysis
1.7.1. Medical Device Manufacturers
1.7.2. 5G Module, Chipset and Connectivity Component Suppliers
1.7.3. Wireless Carriers and Mobile Network Operators
1.7.4. Private 5G Network and Infrastructure Providers
1.7.5. Hospitals and Integrated Delivery Networks
1.7.6. Ambulatory, Diagnostic and Specialty Care Providers
1.7.7. Remote Patient Monitoring and Home Healthcare Providers
1.7.8. Group Purchasing Organizations and Distributors
1.7.9. FDA, CMS, FCC and Other Regulatory Stakeholders

What this section provides: This section establishes the market boundary, study scope, methodology, assumptions, inclusion criteria, and stakeholder ecosystem so clients understand precisely how the U.S. 5G connected medical devices market is defined, measured, validated, and differentiated from the broader IoMT and healthcare connectivity markets.

2. U.S. 5G Connected Medical Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size Opportunity, 2025 vs. 2035
2.8. High-Growth Device and Connectivity Opportunity Areas
2.9. Key Clinical and Commercial Adoption Indicators
2.10. Leading Regional and State-Level Opportunity Pockets

What this section provides: This section gives decision-makers a concise view of market size, CAGR, historical development, forecast direction, technology adoption, priority device categories, major use cases, competitive intensity, and high-growth geographic opportunities.

3. U.S. 5G Connected Medical Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Expansion of Nationwide 5G Coverage and Device Penetration
3.1.2. Rapid Growth of Remote Patient Monitoring and Connected Care
3.1.3. Increasing Medical Device Density Across U.S. Hospitals
3.1.4. Hospital Transition Toward Private 5G and Hybrid Wireless Networks
3.1.5. Growth of Virtual Nursing, Tele-ICU and Decentralized Care Models
3.1.6. Rising Adoption of AI-Enabled and Data-Intensive Medical Devices
3.1.7. Increasing Demand for Continuous Clinical Mobility
3.1.8. Expansion of Cellular-First Home Healthcare Devices
3.2. Restraints and Their Impact Analysis
3.2.1. High Initial Private 5G Infrastructure and Integration Cost
3.2.2. Long Medical Device Product Development and Replacement Cycles
3.2.3. Healthcare Cybersecurity and Data Privacy Concerns
3.2.4. Interoperability with Legacy Wi-Fi and Hospital IT Infrastructure
3.2.5. Device Certification and Multi-Carrier Compatibility Complexity
3.2.6. Uncertain ROI for Non-Mission-Critical 5G Use Cases
3.3. Opportunities and Their Impact Analysis
3.3.1. 5G-Enabled Remote Patient Monitoring Expansion
3.3.2. Private 5G Smart Hospital Deployments
3.3.3. 5G RedCap Medical Wearables and Low-Power Devices
3.3.4. Edge AI and Real-Time Clinical Analytics
3.3.5. Cellular-Connected Medical Imaging and Diagnostics
3.3.6. EMS, Ambulance and Rural Healthcare Connectivity
3.3.7. Virtual Nursing and Centralized Monitoring
3.3.8. eSIM-Enabled Medical Device Lifecycle Management
3.4. Challenges and Their Impact Analysis
3.4.1. Network Reliability and Clinical-Grade Quality of Service
3.4.2. Cybersecurity Lifecycle Management
3.4.3. Fragmented Hospital Wireless Architecture
3.4.4. Private 5G Spectrum and Network Management Complexity
3.4.5. Medical Device Battery and Form-Factor Constraints
3.4.6. Clinical Workflow Integration and Staff Adoption
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. 5G Connectivity Total Cost of Ownership Analysis
3.8. Hospital Capital Procurement Behavior Analysis
3.9. Medical Device Cybersecurity Impact Analysis
3.10. Public 5G vs. Private 5G Clinical Use-Case Assessment

What this section provides: This section explains the technological, clinical, economic, regulatory, security, and operational forces shaping 5G-connected medical device demand and helps clients assess adoption drivers, barriers, commercial opportunities, and execution risks.

4. U.S. 5G Connected Medical Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Healthcare Buyers
4.2.3. Bargaining Power of Device, Chipset and Network Suppliers
4.2.4. Threat of Substitution from Wi-Fi and Alternative Connectivity
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.4.1. Semiconductor and Modem Suppliers
4.4.2. Connectivity Module Manufacturers
4.4.3. Medical Device OEMs
4.4.4. Telecom Operators
4.4.5. Private Network Infrastructure Providers
4.4.6. Systems Integrators
4.4.7. Healthcare Provider Organizations
4.5. U.S. 5G Network Infrastructure and Coverage Landscape
4.6. Private 5G Healthcare Deployment Landscape
4.7. 5G Standalone and Network Slicing Readiness
4.8. 5G RedCap Adoption Landscape
4.9. Edge Computing and AI Integration Analysis
4.10. FDA Regulatory Framework for Connected and Cyber Medical Devices
4.11. FDA Premarket Cybersecurity Requirements
4.12. CMS Remote Patient Monitoring Reimbursement Landscape
4.13. FCC Spectrum and Private Wireless Environment
4.14. HIPAA, Patient Data Privacy and Security Considerations
4.15. Import/Export Restrictions & Tariff Impact
4.16. Government Digital Health and Broadband Initiatives
4.17. Impact of Escalating Geopolitical and Semiconductor Supply Risks
4.18. Hospital IT and Value Analysis Committee Decision Framework
4.19. Network Vendor Qualification and Medical Device Certification Requirements

What this section provides: This section gives clients a complete view of the external operating environment, including regulation, reimbursement, spectrum policy, cybersecurity, network infrastructure, supply chains, pricing, edge computing, private 5G deployment, and hospital technology-procurement dynamics.

5. U.S. 5G Connected Medical Devices Market – By Device Type

5.1. Overview
5.1.1. Segment Share Analysis, By Device Type, 2025 & 2035 (%)
5.1.2. Patient Monitoring and Diagnostic Devices
5.1.2.1. Multi-Parameter Patient Monitoring Systems
5.1.2.2. ECG and Cardiac Monitoring Devices
5.1.2.3. Blood Pressure Monitoring Devices
5.1.2.4. Pulse Oximetry and Respiratory Monitoring Devices
5.1.2.5. Glucose Monitoring Systems
5.1.2.6. Portable and Point-of-Care Diagnostic Devices
5.1.3. Therapeutic and Life-Support Devices
5.1.3.1. Connected Infusion Systems
5.1.3.2. Respiratory Therapy Devices
5.1.3.3. Insulin Delivery Systems
5.1.3.4. Dialysis and Renal Care Devices
5.1.3.5. Connected Implantable Therapeutic Devices
5.1.4. Medical Imaging and Visualization Systems
5.1.4.1. Portable Ultrasound Systems
5.1.4.2. Mobile Imaging Systems
5.1.4.3. Connected Endoscopy and Visualization Platforms
5.1.4.4. Digital Pathology and Imaging Devices
5.1.5. Surgical, Robotic and Interventional Systems
5.1.5.1. Robotic Surgical Systems
5.1.5.2. Image-Guided Intervention Systems
5.1.5.3. Connected Operating Room Systems
5.1.5.4. Procedural Navigation and Remote Support Platforms
5.1.6. Wearable and Home Healthcare Devices
5.1.6.1. Cardiac Wearables and Patches
5.1.6.2. Diabetes Management Devices
5.1.6.3. Respiratory and Sleep Monitoring Devices
5.1.6.4. Home Vital-Sign Monitoring Devices
5.1.6.5. Rehabilitation and Mobility Monitoring Devices

What this section provides: This section identifies which 5G-connected medical device categories are expected to generate the largest revenue pools and fastest growth through 2035, including monitoring, therapeutic, imaging, surgical, wearable, and home healthcare technologies.

6. U.S. 5G Connected Medical Devices Market – By Connectivity Architecture

6.1. Overview
6.1.1. Segment Share Analysis, By Connectivity Architecture, 2025 & 2035 (%)
6.1.2. Public 5G Network Connectivity
6.1.2.1. Nationwide Carrier-Based Connectivity
6.1.2.2. Multi-Carrier Medical Device Connectivity
6.1.2.3. Public 5G with Priority Connectivity
6.1.3. Private 5G Network Connectivity
6.1.3.1. Hospital Campus Private 5G
6.1.3.2. Health System Enterprise Private 5G
6.1.3.3. CBRS-Based Private Cellular Networks
6.1.4. Hybrid 5G and Wi-Fi Architectures
6.1.4.1. 5G/Wi-Fi Device Failover
6.1.4.2. Wi-Fi Indoor and 5G Outdoor Mobility
6.1.4.3. Hybrid Hospital Enterprise Networks
6.1.5. 5G Edge-Enabled Connectivity
6.1.5.1. On-Premises Healthcare Edge
6.1.5.2. Carrier Multi-Access Edge Computing
6.1.5.3. Edge AI-Enabled Medical Device Networks
6.1.6. 5G RedCap and Low-Power Cellular Architecture
6.1.6.1. RedCap Medical Wearables
6.1.6.2. Reduced-Power Monitoring Devices
6.1.6.3. Next-Generation Cellular Medical Sensors

What this section provides: This section evaluates how public 5G, private 5G, hybrid networking, edge-enabled connectivity, and emerging RedCap architectures are expected to shape device design, deployment economics, mobility, performance, and commercial adoption.

7. U.S. 5G Connected Medical Devices Market – By Application

7.1. Overview
7.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
7.1.2. Remote Patient Monitoring
7.1.2.1. Cardiovascular Monitoring
7.1.2.2. Diabetes Monitoring
7.1.2.3. Respiratory Monitoring
7.1.2.4. Post-Discharge Monitoring
7.1.2.5. Chronic Disease Management
7.1.3. Real-Time Hospital Patient Monitoring
7.1.3.1. Bedside Monitoring
7.1.3.2. Continuous Telemetry
7.1.3.3. Patient Transport Monitoring
7.1.3.4. Centralized Surveillance and Virtual Nursing
7.1.4. Telemedicine and Virtual Care
7.1.4.1. Tele-ICU
7.1.4.2. Virtual Nursing
7.1.4.3. Remote Specialist Consultation
7.1.4.4. Rural Telemedicine
7.1.4.5. Connected Diagnostic Examination
7.1.5. Connected Surgery and Procedural Support
7.1.5.1. Robotic Surgery Connectivity
7.1.5.2. Remote Surgical Proctoring
7.1.5.3. Connected Procedural Video
7.1.5.4. AR/VR-Assisted Clinical Workflows
7.1.5.5. Remote Technical Device Support
7.1.6. Asset Intelligence and Clinical Operations
7.1.6.1. Medical Equipment Location and Tracking
7.1.6.2. Smart Bed Connectivity
7.1.6.3. Device Utilization Monitoring
7.1.6.4. Predictive Maintenance
7.1.6.5. Workflow and Equipment Availability Management

What this section provides: This section helps clients prioritize the clinical and operational use cases with the strongest 5G value proposition, including remote monitoring, hospital surveillance, virtual care, connected procedural workflows, and medical-device fleet intelligence.

8. U.S. 5G Connected Medical Devices Market – By End User

8.1. Overview
8.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
8.1.2. Hospitals and Integrated Health Systems
8.1.2.1. Academic Medical Centers
8.1.2.2. Large Integrated Delivery Networks
8.1.2.3. Community Hospitals
8.1.2.4. Specialty Hospitals
8.1.3. Ambulatory and Specialty Care Centers
8.1.3.1. Ambulatory Surgery Centers
8.1.3.2. Cardiology Centers
8.1.3.3. Oncology Centers
8.1.3.4. Dialysis Centers
8.1.3.5. Multispecialty Clinics
8.1.4. Diagnostic and Imaging Providers
8.1.4.1. Diagnostic Imaging Centers
8.1.4.2. Mobile Imaging Providers
8.1.4.3. Independent Diagnostic Testing Facilities
8.1.5. Home Healthcare and Remote Monitoring Providers
8.1.5.1. Home Health Agencies
8.1.5.2. Remote Patient Monitoring Service Providers
8.1.5.3. Hospital-at-Home Programs
8.1.5.4. Chronic Care Management Providers
8.1.6. Emergency, EMS and Rural Care Providers
8.1.6.1. Emergency Medical Services
8.1.6.2. Ambulance Networks
8.1.6.3. Critical Access Hospitals
8.1.6.4. Rural Health Clinics
8.1.6.5. Mobile and Community Health Programs

What this section provides: This section explains which healthcare customer groups are expected to drive 5G-connected medical device adoption, enterprise network investment, recurring monitoring demand, and next-generation connected-care deployment.

9. U.S. 5G Connected Medical Devices Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct Medical Device Manufacturer Procurement
9.1.3. Integrated Delivery Network Enterprise Contracts
9.1.4. Group Purchasing Organization Contracts
9.1.5. Distributor and Specialty Technology Supplier Sales
9.1.6. Telecom Operator and Network Integrator Bundled Contracts
9.1.7. Private 5G Managed Service Contracts
9.1.8. Remote Patient Monitoring Program Procurement
9.1.9. Home Healthcare and Direct-to-Provider Device Programs

What this section provides: This section helps clients understand how 5G-connected medical devices are purchased in the U.S., including OEM sales, IDN contracting, GPO influence, telecom partnerships, systems integration, managed private-network contracts, and RPM procurement models.

10. U.S. 5G Connected Medical Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional 5G Coverage and Network Readiness Analysis
10.1.4. Regional Hospital Infrastructure and Connected Device Adoption Analysis
10.1.5. Regional Private 5G Deployment Analysis
10.1.6. Regional RPM, Virtual Care and Home Healthcare Adoption
10.1.7. Regional Reimbursement and Procurement Dynamics
10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region 5G Medical Device Manufacturers, Telecom Providers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region 5G Medical Device Manufacturers, Telecom Providers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region 5G Medical Device Manufacturers, Telecom Providers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region 5G Medical Device Manufacturers, Telecom Providers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Connectivity Architecture, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level analysis across all 50 U.S. states, helping clients identify 5G-readiness hotspots, private-network deployment opportunities, connected-device adoption centers, RPM demand pockets, health-system procurement clusters, and state-level commercial opportunities.

11. U.S. 5G Connected Medical Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Competitive Benchmarking Analysis
11.3. Company Positioning Matrix
11.3.1. Leaders
11.3.2. Challengers
11.3.3. Innovators
11.3.4. Emerging Players
11.4. Company Profiles
11.4.1. Abbott Laboratories
11.4.2. Medtronic
11.4.3. GE HealthCare
11.4.4. Philips Healthcare
11.4.5. Siemens Healthineers
11.4.6. Baxter International
11.4.7. Becton, Dickinson and Company
11.4.8. Boston Scientific Corporation
11.4.9. Johnson & Johnson MedTech
11.4.10. Dexcom
11.4.11. Insulet Corporation
11.4.12. ResMed
11.4.13. iRhythm Technologies
11.4.14. Masimo
11.4.15. Stryker
11.4.16. Zimmer Biomet
11.4.17. Verizon Business
11.4.18. AT&T
11.4.19. T-Mobile for Business
11.4.20. Ericsson
11.4.21. Nokia
11.4.22. Qualcomm Technologies
11.4.23. Cisco Systems
11.4.24. Celona
11.4.25. CommScope
11.5. Competitive Strategy Analysis
11.5.1. Medical Device OEM Connectivity Strategies
11.5.2. Telecom–Medtech Strategic Partnerships
11.5.3. Private 5G Hospital Partnership Models
11.5.4. Embedded Connectivity and eSIM Strategies
11.5.5. Edge Computing and AI Partnerships
11.5.6. Cybersecurity Differentiation Strategies
11.6. Mergers, Acquisitions and Strategic Investments
11.7. Partnerships, Alliances and Pilot Deployments
11.8. Product Launch and Commercialization Analysis

Note: Each company profile will include company overview, relevant connected medical device or 5G healthcare portfolio, U.S. market strategy, financial positioning where applicable, product innovation, 5G/private-network capabilities, regulatory developments, partnerships, hospital deployments, and recent strategic developments.

What this section provides: This section gives clients competitor benchmarking, market-position visibility, device and network portfolio positioning, partnership intelligence, innovation direction, and strategic analysis of the companies shaping the U.S. 5G connected medical devices ecosystem.

12. U.S. 5G Connected Medical Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. 5G Standalone Networks
12.2.2. Network Slicing for Clinical Applications
12.2.3. 5G RedCap Medical Devices
12.2.4. Embedded eSIM and Remote SIM Provisioning
12.2.5. Private 5G Smart Hospitals
12.2.6. Edge AI-Enabled Medical Devices
12.2.7. AI-Driven Remote Patient Monitoring
12.2.8. Connected Surgical and Robotic Systems
12.2.9. Hospital-at-Home Connectivity
12.2.10. Next-Generation Wearable Biosensors
12.3. Public 5G vs. Private 5G Adoption Outlook
12.4. Wi-Fi 7 and 5G Convergence Outlook
12.5. Emerging Business Trends
12.6. Medical Device Connectivity-as-a-Service Models
12.7. Business Opportunities for Startups and Existing Players
12.8. Investment Prioritization Matrix
12.9. Clinical Use-Case Commercialization Timeline, 2026–2035
12.10. Long-Term Market Structure and Consolidation Outlook

What this section provides: This section prepares clients for technology transitions, future connectivity architectures, device-platform evolution, business-model changes, investment priorities, and commercialization scenarios likely to reshape the U.S. 5G connected medical devices market through 2035.

13. U.S. 5G Connected Medical Devices Market: Strategic Recommendations

13.1. Recommendations for Medical Device Manufacturers
13.2. Recommendations for Hospitals and Integrated Health Systems
13.3. Recommendations for Telecom Operators
13.4. Recommendations for Private 5G Network Providers
13.5. Recommendations for Semiconductor and Connectivity Module Companies
13.6. Recommendations for Investors and Private Equity Firms
13.7. Recommendations for Distributors and Technology Integrators
13.8. Recommendations for Remote Patient Monitoring Providers
13.9. Recommendations for New Entrants and Startups
13.10. Go-to-Market Strategy Considerations
13.11. Hospital Enterprise Account Strategy
13.12. Public vs. Private Network Product Positioning
13.13. Product Positioning and Portfolio Expansion Guidance
13.14. FDA Cybersecurity and Regulatory Readiness Strategy
13.15. Reimbursement-Aligned Commercialization Strategy
13.16. Partnership and Ecosystem Development Strategy

What this section provides: This section converts market intelligence into actionable strategies for product development, hospital commercialization, connectivity partnerships, regulatory readiness, geographic expansion, portfolio positioning, investment decisions, and competitive differentiation.

14. U.S. 5G Connected Medical Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Market Definition Limitation
14.3. Data Use Limitation
14.4. Forecasting Limitation
14.5. Technology Adoption Assumptions
14.6. Regulatory and Reimbursement Limitation
14.7. Legal Disclaimer
14.8. Third-Party Data Disclaimer

What this section provides: This section clarifies the report’s scope boundaries, market-estimation limitations, forecast assumptions, technology adoption uncertainties, regulatory considerations, third-party data-use terms, and legal limitations.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. 5G Connected Medical Devices Market: Market Definition and Scope
TABLE 3: U.S. 5G Connected Medical Devices Market: Research Methodology Framework
TABLE 4: U.S. 5G Connected Medical Devices Market: Key Assumptions
TABLE 5: U.S. 5G Connected Medical Devices Market: Market Ecosystem Overview
TABLE 6: U.S. 5G Connected Medical Devices Market: Stakeholder Analysis
TABLE 7: U.S. 5G Connected Medical Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. 5G Connected Medical Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. 5G Connected Medical Devices Market: Market Attractiveness Index
TABLE 10: U.S. 5G Connected Medical Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. 5G Connected Medical Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. 5G Connected Medical Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. 5G Connected Medical Devices Market: Drivers; Impact Analysis
TABLE 14: U.S. 5G Connected Medical Devices Market: Restraints; Impact Analysis
TABLE 15: U.S. 5G Connected Medical Devices Market: Opportunities; Impact Analysis
TABLE 16: U.S. 5G Connected Medical Devices Market: Challenges; Impact Analysis
TABLE 17: U.S. 5G Connected Medical Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 18: U.S. 5G Connected Medical Devices Market: Clinical Workflow Economics Matrix
TABLE 19: U.S. 5G Connected Medical Devices Market: 5G Connectivity Total Cost of Ownership Matrix
TABLE 20: U.S. 5G Connected Medical Devices Market: Hospital Capital Procurement Behavior Matrix
TABLE 21: U.S. 5G Connected Medical Devices Market: PESTEL Analysis
TABLE 22: U.S. 5G Connected Medical Devices Market: Porter’s Five Forces Analysis
TABLE 23: U.S. 5G Connected Medical Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 24: U.S. 5G Connected Medical Devices Market: Value Chain Analysis
TABLE 25: U.S. 5G Connected Medical Devices Market: Supply Chain Analysis
TABLE 26: U.S. 5G Connected Medical Devices Market: U.S. 5G Network Infrastructure and Coverage Landscape
TABLE 27: U.S. 5G Connected Medical Devices Market: Private 5G Healthcare Deployment Landscape
TABLE 28: U.S. 5G Connected Medical Devices Market: 5G Standalone and Network Slicing Readiness
TABLE 29: U.S. 5G Connected Medical Devices Market: 5G RedCap Adoption Landscape
TABLE 30: U.S. 5G Connected Medical Devices Market: Edge Computing and AI Integration Analysis
TABLE 31: U.S. 5G Connected Medical Devices Market: FDA Regulatory Framework Analysis
TABLE 32: U.S. 5G Connected Medical Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 33: U.S. 5G Connected Medical Devices Market: FCC Spectrum and Private Wireless Environment
TABLE 34: U.S. 5G Connected Medical Devices Market: HIPAA and Cybersecurity Considerations
TABLE 35: U.S. 5G Connected Medical Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 36: U.S. 5G Connected Medical Devices Market: Government Digital Health and Broadband Initiatives
TABLE 37: U.S. 5G Connected Medical Devices Market: Hospital IT and Value Analysis Committee Decision Framework
TABLE 38: U.S. 5G Connected Medical Devices Market: Device Type Snapshot, 2025
TABLE 39: Segment Dashboard; Definition and Scope, by Device Type
TABLE 40: U.S. 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 41: U.S. 5G Connected Medical Devices Market: Segment Share Analysis, by Device Type, 2025 & 2035 (%)
TABLE 42: U.S. 5G Connected Medical Devices Market: Patient Monitoring and Diagnostic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 43: U.S. 5G Connected Medical Devices Market: Therapeutic and Life-Support Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 44: U.S. 5G Connected Medical Devices Market: Medical Imaging and Visualization Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: U.S. 5G Connected Medical Devices Market: Surgical, Robotic and Interventional Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: U.S. 5G Connected Medical Devices Market: Wearable and Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: U.S. 5G Connected Medical Devices Market: Connectivity Architecture Snapshot, 2025
TABLE 48: Segment Dashboard; Definition and Scope, by Connectivity Architecture
TABLE 49: U.S. 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 50: U.S. 5G Connected Medical Devices Market: Segment Share Analysis, by Connectivity Architecture, 2025 & 2035 (%)
TABLE 51: U.S. 5G Connected Medical Devices Market: Public 5G Network Connectivity Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: U.S. 5G Connected Medical Devices Market: Private 5G Network Connectivity Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: U.S. 5G Connected Medical Devices Market: Hybrid 5G and Wi-Fi Architectures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. 5G Connected Medical Devices Market: 5G Edge-Enabled Connectivity Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: U.S. 5G Connected Medical Devices Market: 5G RedCap and Low-Power Cellular Architecture Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. 5G Connected Medical Devices Market: Application Snapshot, 2025
TABLE 57: Segment Dashboard; Definition and Scope, by Application
TABLE 58: U.S. 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 59: U.S. 5G Connected Medical Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 60: U.S. 5G Connected Medical Devices Market: Remote Patient Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: U.S. 5G Connected Medical Devices Market: Real-Time Hospital Patient Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: U.S. 5G Connected Medical Devices Market: Telemedicine and Virtual Care Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: U.S. 5G Connected Medical Devices Market: Connected Surgery and Procedural Support Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: U.S. 5G Connected Medical Devices Market: Asset Intelligence and Clinical Operations Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. 5G Connected Medical Devices Market: End User Snapshot, 2025
TABLE 66: Segment Dashboard; Definition and Scope, by End User
TABLE 67: U.S. 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 68: U.S. 5G Connected Medical Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 69: U.S. 5G Connected Medical Devices Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 70: U.S. 5G Connected Medical Devices Market: Ambulatory and Specialty Care Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: U.S. 5G Connected Medical Devices Market: Diagnostic and Imaging Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: U.S. 5G Connected Medical Devices Market: Home Healthcare and Remote Monitoring Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: U.S. 5G Connected Medical Devices Market: Emergency, EMS and Rural Care Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. 5G Connected Medical Devices Market: Procurement Channel Snapshot, 2025
TABLE 75: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 76: U.S. 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 77: U.S. 5G Connected Medical Devices Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 78: U.S. 5G Connected Medical Devices Market: Direct Medical Device Manufacturer Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 79: U.S. 5G Connected Medical Devices Market: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 80: U.S. 5G Connected Medical Devices Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 81: U.S. 5G Connected Medical Devices Market: Distributor and Specialty Technology Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: U.S. 5G Connected Medical Devices Market: Telecom Operator and Network Integrator Bundled Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: U.S. 5G Connected Medical Devices Market: Private 5G Managed Service Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: U.S. 5G Connected Medical Devices Market: Remote Patient Monitoring Program Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 85: U.S. 5G Connected Medical Devices Market: Home Healthcare and Direct-to-Provider Device Programs Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 86: U.S. 5G Connected Medical Devices Market: Regional Snapshot, 2025
TABLE 87: Segment Dashboard; Definition and Scope, by Region
TABLE 88: U.S. 5G Connected Medical Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 89: U.S. 5G Connected Medical Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 90: West Region U.S. 5G Connected Medical Devices Market: Regional Overview and Trends
TABLE 91: West Region U.S. 5G Connected Medical Devices Market: Key Manufacturers, Telecom Providers and Procurement Ecosystem
TABLE 92: West Region U.S. 5G Connected Medical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 93: West Region U.S. 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 94: West Region U.S. 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 95: West Region U.S. 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 96: West Region U.S. 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 97: West Region U.S. 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 98: California 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 99: California 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 100: California 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 101: California 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 102: California 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 103: Washington 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 104: Washington 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 105: Washington 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 106: Washington 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 107: Washington 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 108: Arizona 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 109: Arizona 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 110: Arizona 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 111: Arizona 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 112: Arizona 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 113: Colorado 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 114: Colorado 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 115: Colorado 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 116: Colorado 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 117: Colorado 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 118: Oregon 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 119: Oregon 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 120: Oregon 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 121: Oregon 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 122: Oregon 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 123: Utah 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 124: Utah 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 125: Utah 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 126: Utah 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 127: Utah 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 128: Nevada 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 129: Nevada 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 130: Nevada 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 131: Nevada 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 132: Nevada 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 133: New Mexico 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 134: New Mexico 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 135: New Mexico 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 136: New Mexico 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 137: New Mexico 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 138: Idaho 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 139: Idaho 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 140: Idaho 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 141: Idaho 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 142: Idaho 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 143: Montana 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 144: Montana 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 145: Montana 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 146: Montana 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 147: Montana 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 148: Wyoming 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 149: Wyoming 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 150: Wyoming 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 151: Wyoming 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 152: Wyoming 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 153: Alaska 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 154: Alaska 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 155: Alaska 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 156: Alaska 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 157: Alaska 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 158: Hawaii 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 159: Hawaii 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 160: Hawaii 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 161: Hawaii 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 162: Hawaii 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 163: Northeast Region U.S. 5G Connected Medical Devices Market: Regional Overview and Trends
TABLE 164: Northeast Region U.S. 5G Connected Medical Devices Market: Key Manufacturers, Telecom Providers and Procurement Ecosystem
TABLE 165: Northeast Region U.S. 5G Connected Medical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 166: Northeast Region U.S. 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 167: Northeast Region U.S. 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 168: Northeast Region U.S. 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 169: Northeast Region U.S. 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 170: Northeast Region U.S. 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 171: New York 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 172: New York 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 173: New York 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 174: New York 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 175: New York 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 176: Massachusetts 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 177: Massachusetts 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 178: Massachusetts 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 179: Massachusetts 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 180: Massachusetts 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 181: New Jersey 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 182: New Jersey 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 183: New Jersey 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 184: New Jersey 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 185: New Jersey 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 186: Pennsylvania 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 187: Pennsylvania 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 188: Pennsylvania 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 189: Pennsylvania 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 190: Pennsylvania 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 191: Connecticut 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 192: Connecticut 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 193: Connecticut 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 194: Connecticut 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 195: Connecticut 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 196: Maine 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 197: Maine 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 198: Maine 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 199: Maine 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 200: Maine 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 201: Vermont 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 202: Vermont 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 203: Vermont 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 204: Vermont 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 205: Vermont 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 206: New Hampshire 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 207: New Hampshire 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 208: New Hampshire 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 209: New Hampshire 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 210: New Hampshire 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 211: Rhode Island 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 212: Rhode Island 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 213: Rhode Island 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 214: Rhode Island 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 215: Rhode Island 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 216: Delaware 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 217: Delaware 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 218: Delaware 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 219: Delaware 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 220: Delaware 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 221: South Region U.S. 5G Connected Medical Devices Market: Regional Overview and Trends
TABLE 222: South Region U.S. 5G Connected Medical Devices Market: Key Manufacturers, Telecom Providers and Procurement Ecosystem
TABLE 223: South Region U.S. 5G Connected Medical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 224: South Region U.S. 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 225: South Region U.S. 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 226: South Region U.S. 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 227: South Region U.S. 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 228: South Region U.S. 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 229: Texas 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 230: Texas 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 231: Texas 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 232: Texas 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 233: Texas 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 234: Florida 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 235: Florida 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 236: Florida 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 237: Florida 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 238: Florida 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 239: Georgia 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 240: Georgia 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 241: Georgia 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 242: Georgia 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 243: Georgia 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 244: North Carolina 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 245: North Carolina 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 246: North Carolina 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 247: North Carolina 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 248: North Carolina 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 249: Tennessee 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 250: Tennessee 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 251: Tennessee 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 252: Tennessee 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 253: Tennessee 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 254: South Carolina 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 255: South Carolina 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 256: South Carolina 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 257: South Carolina 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 258: South Carolina 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 259: Alabama 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 260: Alabama 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 261: Alabama 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 262: Alabama 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 263: Alabama 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 264: Mississippi 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 265: Mississippi 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 266: Mississippi 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 267: Mississippi 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 268: Mississippi 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 269: Louisiana 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 270: Louisiana 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 271: Louisiana 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 272: Louisiana 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 273: Louisiana 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 274: Arkansas 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 275: Arkansas 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 276: Arkansas 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 277: Arkansas 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 278: Arkansas 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 279: Kentucky 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 280: Kentucky 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 281: Kentucky 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 282: Kentucky 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 283: Kentucky 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 284: Oklahoma 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 285: Oklahoma 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 286: Oklahoma 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 287: Oklahoma 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 288: Oklahoma 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 289: Virginia 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 290: Virginia 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 291: Virginia 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 292: Virginia 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 293: Virginia 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 294: Maryland 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 295: Maryland 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 296: Maryland 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 297: Maryland 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 298: Maryland 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 299: West Virginia 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 300: West Virginia 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 301: West Virginia 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 302: West Virginia 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 303: West Virginia 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 304: Midwest Region U.S. 5G Connected Medical Devices Market: Regional Overview and Trends
TABLE 305: Midwest Region U.S. 5G Connected Medical Devices Market: Key Manufacturers, Telecom Providers and Procurement Ecosystem
TABLE 306: Midwest Region U.S. 5G Connected Medical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 307: Midwest Region U.S. 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 308: Midwest Region U.S. 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 309: Midwest Region U.S. 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 310: Midwest Region U.S. 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 311: Midwest Region U.S. 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 312: Illinois 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 313: Illinois 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 314: Illinois 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 315: Illinois 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 316: Illinois 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 317: Ohio 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 318: Ohio 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 319: Ohio 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 320: Ohio 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 321: Ohio 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 322: Michigan 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 323: Michigan 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 324: Michigan 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 325: Michigan 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 326: Michigan 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 327: Minnesota 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 328: Minnesota 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 329: Minnesota 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 330: Minnesota 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 331: Minnesota 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 332: Indiana 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 333: Indiana 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 334: Indiana 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 335: Indiana 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 336: Indiana 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 337: Wisconsin 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 338: Wisconsin 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 339: Wisconsin 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 340: Wisconsin 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 341: Wisconsin 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 342: Missouri 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 343: Missouri 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 344: Missouri 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 345: Missouri 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 346: Missouri 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 347: Iowa 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 348: Iowa 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 349: Iowa 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 350: Iowa 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 351: Iowa 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 352: Kansas 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 353: Kansas 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 354: Kansas 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 355: Kansas 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 356: Kansas 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 357: Nebraska 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 358: Nebraska 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 359: Nebraska 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 360: Nebraska 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 361: Nebraska 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 362: North Dakota 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 363: North Dakota 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 364: North Dakota 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 365: North Dakota 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 366: North Dakota 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 367: South Dakota 5G Connected Medical Devices Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 368: South Dakota 5G Connected Medical Devices Market, by Connectivity Architecture, 2021–2035 (US$ Billion)
TABLE 369: South Dakota 5G Connected Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 370: South Dakota 5G Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 371: South Dakota 5G Connected Medical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 372: U.S. 5G Connected Medical Devices Market: Competitive Landscape Snapshot, 2025
TABLE 373: U.S. 5G Connected Medical Devices Market: Key Company Market Share Analysis, 2025
TABLE 374: U.S. 5G Connected Medical Devices Market: Company Positioning Matrix
TABLE 375: U.S. 5G Connected Medical Devices Market: Product and Connectivity Portfolio Benchmarking of Key Players
TABLE 376: U.S. 5G Connected Medical Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 377: Abbott Laboratories: Company Profile
TABLE 378: Medtronic: Company Profile
TABLE 379: GE HealthCare: Company Profile
TABLE 380: Philips Healthcare: Company Profile
TABLE 381: Siemens Healthineers: Company Profile
TABLE 382: Baxter International: Company Profile
TABLE 383: Becton, Dickinson and Company: Company Profile
TABLE 384: Boston Scientific Corporation: Company Profile
TABLE 385: Johnson & Johnson MedTech: Company Profile
TABLE 386: Dexcom: Company Profile
TABLE 387: Insulet Corporation: Company Profile
TABLE 388: ResMed: Company Profile
TABLE 389: iRhythm Technologies: Company Profile
TABLE 390: Masimo: Company Profile
TABLE 391: Stryker: Company Profile
TABLE 392: Zimmer Biomet: Company Profile
TABLE 393: Verizon Business: Company Profile
TABLE 394: AT&T: Company Profile
TABLE 395: T-Mobile for Business: Company Profile
TABLE 396: Ericsson: Company Profile
TABLE 397: Nokia: Company Profile
TABLE 398: Qualcomm Technologies: Company Profile
TABLE 399: Cisco Systems: Company Profile
TABLE 400: Celona: Company Profile
TABLE 401: CommScope: Company Profile
TABLE 402: U.S. 5G Connected Medical Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 403: U.S. 5G Connected Medical Devices Market: Disruptive Technologies Impact Matrix
TABLE 404: U.S. 5G Connected Medical Devices Market: Public 5G vs. Private 5G Adoption Outlook
TABLE 405: U.S. 5G Connected Medical Devices Market: Emerging Business Trends
TABLE 406: U.S. 5G Connected Medical Devices Market: Business Opportunities for Startups and Existing Players
TABLE 407: U.S. 5G Connected Medical Devices Market: Investment Prioritization Matrix
TABLE 408: U.S. 5G Connected Medical Devices Market: Clinical Use-Case Commercialization Timeline, 2026–2035
TABLE 409: U.S. 5G Connected Medical Devices Market: Strategic Recommendations for Medical Device Manufacturers
TABLE 410: U.S. 5G Connected Medical Devices Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 411: U.S. 5G Connected Medical Devices Market: Strategic Recommendations for Telecom Operators and Private 5G Providers
TABLE 412: U.S. 5G Connected Medical Devices Market: Strategic Recommendations for Semiconductor and Connectivity Module Companies
TABLE 413: U.S. 5G Connected Medical Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 414: U.S. 5G Connected Medical Devices Market: Strategic Recommendations for Distributors and Technology Integrators
TABLE 415: U.S. 5G Connected Medical Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 416: U.S. 5G Connected Medical Devices Market: Go-to-Market Strategy Considerations
TABLE 417: U.S. 5G Connected Medical Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 418: U.S. 5G Connected Medical Devices Market: FDA Cybersecurity and Regulatory Readiness Strategy
TABLE 419: U.S. 5G Connected Medical Devices Market: Scope Limitation
TABLE 420: U.S. 5G Connected Medical Devices Market: Market Definition Limitation
TABLE 421: U.S. 5G Connected Medical Devices Market: Data Use Limitation
TABLE 422: U.S. 5G Connected Medical Devices Market: Forecasting Limitation
TABLE 423: U.S. 5G Connected Medical Devices Market: Technology Adoption Assumptions
TABLE 424: U.S. 5G Connected Medical Devices Market: Regulatory and Reimbursement Limitation
TABLE 425: U.S. 5G Connected Medical Devices Market: Legal Disclaimer
TABLE 426: U.S. 5G Connected Medical Devices Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. 5G Connected Medical Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: Supply Chain Analysis
FIGURE 5: PESTEL Analysis
FIGURE 6: Porter’s Five Forces Analysis
FIGURE 7: Market Attractiveness Analysis
FIGURE 8: Market Dynamics
FIGURE 9: Innovation & Patent Landscape, 2021–2025
FIGURE 10: Clinical Workflow Economics Framework
FIGURE 11: 5G Connectivity Total Cost of Ownership Framework
FIGURE 12: Hospital Capital Procurement Decision Framework
FIGURE 13: U.S. 5G Connected Medical Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 14: U.S. 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 15: U.S. 5G Connected Medical Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 16: Device Type Segment Market Share Analysis, 2025 & 2035
FIGURE 17: Device Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 18: Patient Monitoring and Diagnostic Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 19: Therapeutic and Life-Support Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Medical Imaging and Visualization Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Surgical, Robotic and Interventional Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Wearable and Home Healthcare Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Connectivity Architecture Segment Market Share Analysis, 2025 & 2035
FIGURE 24: Connectivity Architecture Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Public 5G Network Connectivity Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Private 5G Network Connectivity Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Hybrid 5G and Wi-Fi Architectures Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: 5G Edge-Enabled Connectivity Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: 5G RedCap and Low-Power Cellular Architecture Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 31: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Remote Patient Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Real-Time Hospital Patient Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Telemedicine and Virtual Care Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Connected Surgery and Procedural Support Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Asset Intelligence and Clinical Operations Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 38: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Ambulatory and Specialty Care Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Diagnostic and Imaging Providers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Home Healthcare and Remote Monitoring Providers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Emergency, EMS and Rural Care Providers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 45: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Direct Medical Device Manufacturer Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Distributor and Specialty Technology Supplier Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Telecom Operator and Network Integrator Bundled Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Private 5G Managed Service Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Remote Patient Monitoring Program Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Home Healthcare and Direct-to-Provider Device Programs Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 55: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: West Region U.S. 5G Connected Medical Devices Market Share and Leading Players, 2025
FIGURE 57: West Region Market Share Analysis by State, 2025
FIGURE 58: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: California 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Washington 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Arizona 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: Colorado 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Oregon 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Utah 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Nevada 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: New Mexico 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Idaho 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Montana 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Wyoming 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Alaska 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Hawaii 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Northeast Region U.S. 5G Connected Medical Devices Market Share and Leading Players, 2025
FIGURE 73: Northeast Region Market Share Analysis by State, 2025
FIGURE 74: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: New York 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Massachusetts 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: New Jersey 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Pennsylvania 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Connecticut 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Maine 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Vermont 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: New Hampshire 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: Rhode Island 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Delaware 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: South Region U.S. 5G Connected Medical Devices Market Share and Leading Players, 2025
FIGURE 86: South Region Market Share Analysis by State, 2025
FIGURE 87: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Texas 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Florida 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Georgia 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: North Carolina 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Tennessee 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: South Carolina 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Alabama 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Mississippi 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Louisiana 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Arkansas 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Kentucky 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Oklahoma 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Virginia 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Maryland 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: West Virginia 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Midwest Region U.S. 5G Connected Medical Devices Market Share and Leading Players, 2025
FIGURE 104: Midwest Region Market Share Analysis by State, 2025
FIGURE 105: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Illinois 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Ohio 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Michigan 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Minnesota 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Indiana 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Wisconsin 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Missouri 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Iowa 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Kansas 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Nebraska 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: North Dakota 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: South Dakota 5G Connected Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 119: Company Positioning Matrix
FIGURE 120: Key Player Product and Connectivity Portfolio Benchmarking
FIGURE 121: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 122: 5G Connected Medical Device Innovation Roadmap
FIGURE 123: Private 5G Smart Hospital Adoption Roadmap
FIGURE 124: 5G RedCap Medical Device Opportunity Map
FIGURE 125: Remote Patient Monitoring Growth Roadmap
FIGURE 126: Edge AI and Connected Medical Device Integration Roadmap
FIGURE 127: Future Market Scenario Analysis, 2026–2035
FIGURE 128: Disruptive Technologies Impact Matrix
FIGURE 129: Emerging Business Trends Matrix
FIGURE 130: Investment Prioritization Matrix
FIGURE 131: Strategic Growth Roadmap for U.S. 5G Connected Medical Device Companies
FIGURE 132: Go-to-Market Strategy Framework
FIGURE 133: Product Positioning and Portfolio Expansion Framework
FIGURE 134: Report Scope and Disclaimer Framework